Benchmark raised the firm’s price target on Cinemark (CNK) to $40 from $32 and keeps a Buy rating on the shares, noting that the domestic box office in Q4 is currently up 26% year-over-year at the same point in the quarter, which has surpassed the firm’s expectations. This “robust performance underscores the accelerating recovery” of the box office post-pandemic, says the analyst, who anticipates this momentum to persist with a slate of high-quality films set to release in 2025 and beyond.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on CNK:
- Cinemark achieves multiple records during Thanksgiving holiday period
- Cinemark price target raised to $38 from $35 at Wells Fargo
- Cinemark price target raised to $34 from $32 at Macquarie
- Cinemark price target raised to $35 from $31 at Wells Fargo
- Wedbush downgrades Cinemark with shares ‘priced for perfection’
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
